Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chifeng Renhe Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a wholly-owned subsidiary of Renhe Pharmacy Co., Ltd. The company specializes in the production of Traditional Chinese Medicine (TCM) and chemical drugs, with a strong focus on the over-the-counter (OTC) market. Its extensive product portfolio includes treatments for pediatric ailments, respiratory infections, and cardiovascular conditions, produced across multiple GMP-certified facilities in Inner Mongolia. Chifeng Renhe is recognized for its integration of modern manufacturing technologies with traditional herbal formulations. As a key asset within the Renhe Group, the company contributes significantly to the parent organization's nationwide distribution network and brand presence in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chifeng Renhe Pharmaceutical.